UCB Australia
UCB aspires to be the patient-centric global biopharmaceutical leader, transforming the lives of
people with severe diseases.
At UCB our sense of purpose is to help people suffering from immunological conditions lead normal,
everyday lives. Our ambition is to offer them innovative new medicines and ground-breaking
solutions that go beyond the drug. We are committed to enabling cutting-edge scientific research
that is driven by patients’ needs.
ARA NSW-ACT 2024